⚠ COVID-19 INFORMATION: Resources, Vaccine Information
Language: English
Dr. Kaushal brings 13 years of complex surgical, clinical translational expertise and leadership experience to the Cardiovascular-Thoracic Surgery team. Since 2011, Dr. Kaushal developed an expertise in neonatal cardiac surgery, particularly the Norwood Operation. At the University of Maryland School of Medicine, he grew the clinical program by 5-fold establishing excellent outcomes with complex congenital heart surgeries, including complex neonatal surgeries, adult congenital surgeries, and heart transplantation, by maintaining mortality rates and length of stay lower than the national average.
Dr. Kaushal’s research includes prevention of reperfusion injury after heart-bypass, characterization of skeletal and heart muscle gene regulation, and clinical trials with cardiac stem cells in congenital heart disease surgery patients. He is attributed with two inventions: tissue-engineering vascular structures using endothelial cell progenitors and paraxylene films and their therapeutic uses. Dr. Kaushal has four active National Institutes of Health (NIH) grants and two pending NIH grants.
Education: Johns Hopkins University School of Medicine,Baltimore, MD, 1997; Harvard University Graduate School of Arts and Sciences, 1995
Postgraduate Training: Fellowship in pediatric cardiovascular surgery, University of Michigan – Mott Children's Hospital, Ann Arbor, MI, 2006-2007; Fellowship in thoracic surgery, The Johns Hopkins Hospital, Baltimore, MD, 2004-2006; Fellowship in pediatric cardiac surgery, Great Ormand Street Hospital, London, England, 2005; Residency in general surgery, The Johns Hopkins Hospital, Baltimore, MD, 1997-2004
Board Certifications: Congenital cardiac surgery, thoracic surgery, general surgery
Professional Organizations: Society of Thoracic Surgeons
See Northwestern University Faculty Profile >Research Interests: Prevention of reperfusion injury after heart-bypass, characterization of skeletal and heart muscle gene regulation, and clinical trials with cardiac stem cells in congenital heart disease surgery patients
